BACKGROUND. In an androgen-dependent manner, the androgen receptor (AR) bin
ds to the androgen-responsive element (ARE) in the regulatory region of tar
get genes. We hypothesize that an "ARE decoy," a double-stranded oligonucle
otide containing the same DNA sequence as ARE, can inhibit prostatic prolif
eration by competitive inhibition of AR transcriptional activity.
METHODS. We synthesized a 23-mer ARE decoy based on the deduced ARE sequenc
e at the promoter region of the human prostate-specific antigen (PSA) gene.
The nuclear extract was prepared from LNCaP cells, and DNA-protein interac
tions were examined by gel shift assay. Then the antiandrogen effect of the
ARE decoy was studied in LNCaP cells transfected with the ARE decoy by lip
ofection. After 24-hr incubation with 10(-9) M dihydrotestosterone (DHT), i
nduction of apoptosis was examined by DNA fragmentation.
RESULTS. The gel shift assay demonstrated specific binding of the ARE decoy
to the LNCaP nuclear protein which is most likely AR. The transfection exp
eriment showed DNA fragmentation in the ARE decoy-transfected cells despite
the presence of DHT, though not in the cells transfected with the control
decoy.
CONCLUSIONS. The ARE decoy had an antiandrogen effect and induced apoptosis
in LNCaP cells. This ARE decoy may become a potential therapeutic tool for
prostate cancers when combined with a highly efficient transfection method
. (C) 1999 Wiley-Liss, Inc.